Vegetable oil-based hybrid microparticles as a green and biocompatible system for subcutaneous drug delivery

[Display omitted] •Design of a green process to produce vegetable oil-based hybrid microparticles.•Preservation of the biological activity of the loaded estradiol after process.•One week- release profile evaluated in a biphasic system.•Fully biocompatible drug delivery system for subcutaneous admini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2021-01, Vol.592, p.120070-120070, Article 120070
Hauptverfasser: Doufène, Koceïla, Basile, Ilaria, Lebrun, Aurélien, Pirot, Nelly, Escande, Aurélie, Chopineau, Joël, Devoisselle, Jean-Marie, Bettache, Nadir, Aubert-Pouëssel, Anne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Design of a green process to produce vegetable oil-based hybrid microparticles.•Preservation of the biological activity of the loaded estradiol after process.•One week- release profile evaluated in a biphasic system.•Fully biocompatible drug delivery system for subcutaneous administration. The aim of this study was to evidence the ability of vegetable oil-based hybrid microparticles (HMP) to be an efficient and safe drug delivery system after subcutaneous administration. The HMP resulted from combination of a thermostabilized emulsification process and a sol–gel chemistry. First of all, castor oil was successfully silylated by means of (3-Isocyanatopropyl)trimethoxysilane in solvent-free and catalyst-free conditions. Estradiol, as a model drug, was dissolved in silylated castor oil (ICOm) prior to emulsification, and then an optimal sol–gel crosslinking was achieved inside the ICOm microdroplets. The resulting estradiol-loaded microparticles were around 80 µm in size and allowed to entrap 4 wt% estradiol. Their release kinetics in a PBS/octanol biphasic system exhibited a one-week release profile, and the released estradiol was fully active on HeLa ERE-luciferase ERα cells. The hybrid microparticles were cytocompatible during preliminary tests on NIH 3T3 fibroblasts (ISO 10993-5 standard) and they were fully biocompatible after subcutaneous injection on mice (ISO 10993-6 standard) underlining their high potential as a safe and long-acting subcutaneous drug delivery system.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2020.120070